[Department of Error] Department of Error

Kandzari DE, Mauri L, Koolen JJ, et al, for the BIOFLOW V Investigators. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet 2017; 390: 1843 –52—In this Article (published online first on August 26), the online publication date in the footer should have been August 26, 2017, the y-axis scale in figure 2 has been corrected, and a number of typological errors have been corrected.

Source: LANCET - September 15, 2017 Category: General Medicine Tags: Department of Error Source Type: research